Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Ecopipam hydrochloride (HCl) is an investigational drug being studied for several possible diseases. To date, all clinical studies have been done using the ecopipam immediate release (IR) tablet. However, a controlled release (CR) capsule formulation of ecopipam has been produced that may be able to improve its effectiveness and reduce its side effects. The main purpose of this study is to evaluate the safety and tolerability of ecopipam CR capsules when given as single oral dose in healthy volunteers.
Epistemonikos ID: a9c55a7b61230eb992f2db9ce14579e7a94f0986
First added on: May 06, 2024